Suprema, Inc. v. Itc , 626 F. App'x 273 ( 2015 )


Menu:
  •        NOTE: This disposition is nonprecedential.
    United States Court of Appeals
    for the Federal Circuit
    ______________________
    SUPREMA, INC.,
    MENTALIX INCORPORATED,
    Appellants
    v.
    INTERNATIONAL TRADE COMMISSION,
    Appellee
    CROSS MATCH TECHNOLOGIES, INC.,
    Intervenor
    ______________________
    2012-1170
    ______________________
    Appeal from the United States International Trade
    Commission in Investigation No. 337-TA-720.
    ______________________
    Decided: September 14, 2015
    ______________________
    DARRYL MICHAEL WOO, Vinson & Elkins LLP, San
    Francisco, CA, argued for appellants. Also represented by
    ILANA RUBEL, BRYAN ALEXANDER KOHM, DAVID MICHAEL
    LACY KUSTERS, HEATHER N. MEWES, ERIN SIMON, Fenwick
    & West, LLP, San Francisco, CA; JAE WON SONG, Moun-
    tain View, CA; BRADLEY THOMAS MEISSNER, Seattle, WA.
    2                                     SUPREMA, INC.   v. ITC
    CLARK S. CHENEY, Office of the General Counsel,
    United States International Trade Commission, Washing-
    ton, DC, argued for appellee. Also represented by DOMINIC
    L. BIANCHI, ANDREA C. CASSON, CLINT A. GERDINE,
    WAYNE W. HERRINGTON.
    MAXIMILIAN A. GRANT, Latham & Watkins LLP,
    Washington, DC, argued for intervenor. Also represented
    by CLEMENT J. NAPLES, New York, NY; GABRIEL BELL,
    BERT C. REISER, JENNIFER HALBLEIB, Washington, DC.
    MARK R. FREEMAN, Appellate Staff, Civil Division,
    United States Department of Justice, Washington, DC,
    argued for amicus curiae United States. Also represented
    by JOYCE R. BRANDA, SCOTT R. MCINTOSH.
    JAMES ALTMAN, Foster, Murphy, Altman & Nickel,
    PC, Washington, DC, for amicus curiae American Intel-
    lectual Property Law Association. Also represented by F.
    DAVID FOSTER.
    J. MICHAEL JAKES, Finnegan, Henderson, Farabow,
    Garrett & Dunner, LLP, Washington DC, for amicus
    curiae Intellectual Property Owners Association. Also
    represented by HERBERT CLARE WAMSLEY, JR., Intellectu-
    al Property Owners Association, Washington, DC; PHILIP
    STATON JOHNSON, Johnson & Johnson, New Brunswick,
    NJ; KEVIN H. RHODES, 3M Innovative Properties Compa-
    ny, St. Paul, MN.
    CONSTANTINE L. TRELA, JR., Sidley Austin LLP, Chi-
    cago, IL, for amicus curiae Microsoft Corporation. Also
    represented by RICHARD ALAN CEDEROTH, DAVID T.
    PRITIKIN, Chicago, IL; BRIAN R. NESTER, RYAN C. MORRIS,
    Washington, DC; THOMAS ANDREW CULBERT, DAVID E.
    KILLOUGH, Microsoft Corporation, Redmond, WA.
    JOHN THORNE, Kellogg, Huber, Hansen, Todd, Evans
    & Figel, PLLC, Washington, DC, for amici curiae Dell
    SUPREMA, INC.   v. ITC                                   3
    Inc., Adobe Systems, Inc., Ford Motor Co., Hewlett Pack-
    ard Co., LG Display Co., Ltd., LG Electronics, Inc., Net-
    flix, Inc., Samsung Electronics Co., Ltd., SAP America,
    Inc. Also represented by AARON M. PANNER, MELANIE L.
    BOSTWICK.
    DARYL JOSEFFER, King & Spalding LLP, Washington,
    DC, for amicus curiae Google Inc. Also represented by
    ADAM CONRAD, Charlotte, NC; SUZANNE MICHEL, Google
    Inc., Washington, DC.
    ERIC JAY FUES, Finnegan, Henderson, Farabow, Gar-
    rett & Dunner, LLP, Washington, DC, for amicus curiae
    International Trade Commission Trial Lawyers Associa-
    tion. Also represented by T. CY WALKER, Kenyon & Ken-
    yon LLP, Washington, DC.
    JOHN D. HAYNES, Alston & Bird LLP, Atlanta, GA, for
    amici curiae Nokia Corporation, Nokia USA, Inc. Also
    represented by ADAM DAVID SWAIN, Washington, DC.
    ______________________
    Before PROST, Chief Judge, O’MALLEY and REYNA,
    Circuit Judges.
    O’MALLEY, Circuit Judge.
    This appeal, which arises from rulings of the Interna-
    tional Trade Commission (“the Commission”), returns to
    this panel after en banc consideration. We reinstate in its
    entirety the panel’s rulings, dated December 13, 2013, as
    to U.S. Patent Nos. 7,277,562 (“the ’562 patent”) and
    5,900,993 (“the ’993 patent”). See Suprema, Inc. v. ITC,
    
    742 F.3d 1350
    , 1363-71 (Fed. Cir. 2013) (“Suprema I”)
    (Parts III.A, III.B, and V). The en banc Court neither
    considered nor questioned either the conclusions the
    panel reached as to those patents, nor the rationale for
    those conclusions. As to 
    U.S. Patent No. 7,203,344
     (“the
    ’344 patent”), we affirm the Commission’s finding of a
    4                                       SUPREMA, INC.   v. ITC
    violation of 
    19 U.S.C. § 1337
     (“section 337”) and the
    exclusion order predicated thereon.
    BACKGROUND
    This Court previously set forth at length the factual
    background of the present controversy. See generally
    Suprema I, 742 F.3d at 1352-56; Suprema, Inc. v. ITC,
    
    2015 U.S. App. LEXIS 13929
    , *4-13 (Fed. Cir. Aug. 10,
    2015) (en banc) (“Suprema II”). Briefly, Appellee Cross
    Match Technologies, Inc. (“Cross Match”) asserted that
    Appellants Suprema, Inc. and Mentalix, Inc. violated
    section 337 by infringing the ’344 patent, the ’562 patent,
    and the ’993 patent. The Commission found claim 19 of
    the ’344 patent infringed by the combination of certain of
    Suprema’s scanners (RealScan-10, RealScan-D, RealScan-
    10F, and RealScan-DF (collectively, the “accused prod-
    ucts”)) and Software Development Kit (“SDK”) with the
    “segmentation” feature of Mentalix Inc.’s FedSubmit
    software.    The Commission concluded that Mentalix
    directly infringed claim 19 of the ’344 patent and that
    Suprema had induced that infringement. The Commis-
    sion determined that the asserted claims of the ’562
    patent were not infringed, however. The Commission
    further found that Suprema’s RealScan-10 and RealScan-
    10F scanners directly infringe claims 10, 12, and 15 of the
    ’993 patent, and that Appellants failed to prove the as-
    serted claims of the ’993 patent invalid as obvious. Su-
    prema I, 742 F.3d at 1353. Based on these findings, on
    October 24, 2011, the Commission issued a limited exclu-
    sion order directed to certain scanning devices imported
    “by or on behalf of Suprema or Mentalix” and issued a
    cease and desist order directed to Mentalix only. 1 See
    Certain Biometric Scanning Devices, Components Thereof,
    Associated Software, and Products Containing Same,
    1   The cease and desist order is not at issue on ap-
    peal; we address only the propriety of the exclusion order.
    SUPREMA, INC.   v. ITC                                     5
    USITC Inv. No. 337-TA-720, Pub. No. 4366, Limited
    Exclusion Order ¶ 1 (Feb. 2013).
    On appeal, a panel of this Court affirmed the Com-
    mission’s non-infringement ruling regarding the ’562
    patent. Suprema I, 742 F.3d at 1353. The panel also
    affirmed the Commission’s finding of infringement with
    regard to the ’993 patent, and affirmed the Commission’s
    conclusion that Appellants failed to prove the asserted
    ’993 patent claims were invalid as obvious. Id. The panel
    vacated the Commission’s infringement finding on the
    ’344 patent, however, holding that “an exclusion order
    based on a violation of § 1337(a)(1)(B)(i) may not be
    predicated on a theory of induced infringement where no
    direct infringement occurs until post-importation.” Id.
    Accordingly, the original panel did not reach the merits of
    the Commission’s willful blindness or direct infringement
    findings on the ’344 patent. Id.
    After reaching these conclusions, this Court granted
    en banc rehearing and vacated the panel decision. Su-
    prema, Inc. v. ITC, 
    2014 U.S. App. LEXIS 10124
    , at *1-2.
    The en banc Court reversed the panel’s holding as it
    relates to the ’344 patent, and upheld the Commission’s
    interpretation that 
    19 U.S.C. § 1337
     covers “importation
    of goods that, after importation, are used by the importer
    to directly infringe at the inducement of the goods’ seller.”
    Suprema II, at *3-4 (Fed. Cir. Aug. 10, 2015). The en
    banc Court then remanded “for further proceedings
    consistent with this opinion.” Id. at *34-35.
    The en banc Court’s holding did not relate to the pan-
    el’s judgments with respect to the ’562 and ’993 patents.
    Because all aspects of the panel opinion were vacated
    when en banc review was granted, however, having now
    received the appeal on remand, we must address the
    Commission’s findings with respect to all three patents at
    issue. For the reasons explained in the original panel
    opinion, we reinstate the original panel’s holdings with
    6                                       SUPREMA, INC.   v. ITC
    respect to the ’562 and ’993 patents. To be clear, we
    affirm the Commission’s finding of no infringement of the
    ’562 patent. See Suprema I, 742 F.3d at 1368-71(Part V of
    the panel opinion). We further affirm the Commission’s
    conclusions that Suprema infringes the ’993 patent, and
    that Appellants failed to prove invalidity of the ’993
    patent. Id. at 1363-68 (Parts III.A and III.B of the panel
    opinion).
    DISCUSSION
    We now reach the merits of the Commission’s direct
    infringement and willful blindness findings on the ’344
    patent. As noted, the Commission found that Mentalix
    directly infringes claim 19 of the ’344 patent, and that
    Suprema was liable for induced infringement of that
    claim due to Suprema’s willful blindness toward Men-
    talix’s infringement. The Commission found that Su-
    prema performed market research on its competitors’
    patents and products, then actively encouraged Mentalix’s
    activities while willfully blinding itself to the infringing
    nature of those activities. Suprema argues that the
    Commission erred in two ways. First, Suprema argued
    that Mentalix does not directly infringe the ’344 patent.
    Second, Suprema argues that the Commission’s findings
    regarding willful blindness were erroneous. As set forth
    below, because there is substantial evidence in the record
    to support the Commission’s findings on both points, we
    affirm the Commission’s conclusions.
    A. Standard of Review
    “[T]he ultimate issue of the proper construction of a
    claim should be treated as a question of law.” Teva
    Pharms. USA, Inc. v. Sandoz, Inc., 
    135 S. Ct. 831
    , 838
    (U.S. 2015). We review any factual determinations made
    in support of a claim construction with deference. Id. at
    838-39.
    SUPREMA, INC.   v. ITC                                    7
    Patent infringement, whether direct or indirect, is a
    question of fact. i4i Ltd. P’ship v. Microsoft Corp., 
    598 F.3d 831
    , 850 (Fed. Cir. 2010); Schindler Elevator Corp. v.
    Otis Elevator Co., 
    593 F.3d 1275
    , 1281 (Fed. Cir. 2010).
    On appeal, we review the Commission’s factual findings
    for substantial evidence, and the Commission’s legal
    determinations de novo. 
    19 U.S.C. § 1337
    (c); 
    5 U.S.C. § 706
    (2)(E); Intel Corp. v. U.S. Int’l Trade Comm’n, 
    946 F.2d 821
    ,832 (Fed. Cir. 1991).
    B. Background on Claim 19 of the ’344 Patent
    The ’344 patent contains claims drawn to methods
    used by an optical scanning system to detect fingerprint
    images based on shape and area, and to determine finger-
    print quality based on the detected shape and area. ’344
    patent col. 19 ll. 24-38. Claim 19 (the only claim of
    the ’344 patent found infringed) recites such a process:
    A method for capturing and processing a finger-
    print image, the method comprising:
    (a) scanning one or more fingers;
    (b) capturing data representing a corresponding
    fingerprint area;
    (c) filtering the fingerprint image;
    (d) binarizing the filtered fingerprint image;
    (e) detecting a fingerprint area based on a concen-
    tration of black pixels in the binarized fingerprint
    image;
    (f) detecting a fingerprint shape based on an ar-
    rangement of the concentrated black pixels in an
    oval-like shape in the binarized fingerprint image;
    and
    (g) determining whether the detected fingerprint
    area and shape are of acceptable quality.
    8                                        SUPREMA, INC.   v. ITC
    
    Id.
     col. 19 ll. 24-37.
    The operation of the accused products is undisputed.
    The accused products allow for scanning of a fingerprint.
    Then, the accused products perform a pixel-level analysis
    to determine height and width of a fingerprint to draw a
    bounding box.    Suprema’s expert admitted that the
    bounding box determines how fat, thin or short the fin-
    gerprint is.
    The parties also do not dispute that Mentalix provid-
    ed training and demonstrations to the U.S. Census Bu-
    reau regarding how to use the accused products.
    C. Whether Mentalix Directly Infringes Claim 19 of the
    ’344 Patent
    Appellants contend that the Commission’s findings
    regarding direct infringement of steps (e) and (f) of claim
    19 of the ’344 patent were erroneous. For the reasons
    below, we agree with the Commission’s claim construction
    with respect to claim 19. We further find that the Com-
    mission’s rulings as to direct and induced infringement
    are supported by substantial evidence.
    The Commission found step (e) infringed because the
    accused products detect a fingerprint area by identifying
    the fingerprint image in a bounding box. The Commission
    further found step (f) infringed because the accused
    products identify the height and width of the finger print,
    which constitutes detection of characteristics of finger-
    print shape.
    Notably, neither Appellant asked that the Commis-
    sion construe steps (e) and (f). Despite their failure to
    request claim construction, Appellants argue that the
    Commission’s non-infringement finding effectively con-
    strued the claims in a way that ignores any distinction
    between steps (e) and (f) of claim 19 of the ’344 patent.
    With respect to step (e), Appellants argue that the Com-
    mission’s claim construction required no actual detection
    SUPREMA, INC.   v. ITC                                      9
    of “a fingerprint area.” Appellants argue that drawing a
    box around the fingerprint does not detect its area, and
    that therefore the Commission’s interpretation reads out
    “finger print area” from the claim.
    Regarding step (f), Appellants argue that the Com-
    mission conflated it with step (e) and thus required no
    detection of “a fingerprint shape” under step (f). Appel-
    lants argue that the Commission’s interpretation fails to
    give effect to all the terms in the claim. Drawing a box
    around the fingerprint area does not detect the finger-
    print’s shape, Suprema argues, since any shape can be
    contained inside the rectangular bounding box. Suprema
    argues that, to practice step (f), the contours of the image
    must be identified to be an “oval-like shape,” according to
    the claim’s terms. The shape of the pixel arrangement,
    Appellants argue, must play a role in detecting the shape,
    since step (f) specifies that the oval-like shape exists while
    step (e) does not.
    Step (e) requires “detecting a fingerprint area based
    on a concentration of black pixels in the binarized finger-
    print image.” The Commission found that this limitation
    was practiced based on the accused products’ source code,
    and based on expert testimony regarding the accused
    products. The evidence demonstrates that the functions
    find concentrations of black pixels in a fingerprint image,
    and then put a ‘bounding box’ around it. By drawing a
    box around the fingerprints, the Commission concluded
    that the accused functions detect a fingerprint area. The
    Commission’s conclusions were consistent with the teach-
    ings of the ’344 patent, which instruct that a common
    method of detecting fingerprint area is by drawing a
    bounding box around the fingerprints. See ’344 patent
    col.15 ll.43-46 (“In step 708, a fingerprint area is detected.
    Usually, the black areas of the image are concentrated
    around the fingerprints. Thus, the detection step detects
    the areas concentrated by black pixels.”). We thus con-
    10                                      SUPREMA, INC.   v. ITC
    clude that the Commission’s findings with respect to step
    (e) are supported by substantial evidence.
    We also agree with the Commission’s finding that
    Mentalix directly infringes step (f) of claim 19. Step (f)
    requires “detecting a fingerprint shape based on an ar-
    rangement of the concentrated black pixels in an oval-like
    shape in the binarized fingerprint image.” The Commis-
    sion construed step (f) to mean “identifying concentrations
    of black pixels, which have oval-like shapes, to determine
    individual fingerprint areas and shapes.” The Commis-
    sion found that claim 19 covers products that detect
    fingerprint shape through detecting concentrations of
    black pixels within the identified bounded area. We find
    that substantial evidence supports the Commission’s
    finding that step (f) is infringed by the accused products’
    detection of concentrations of black pixels, whether or not
    the system defines the outlines of an oval. This reading
    finds support in the patent specification, which states
    that “[i]n step 710, fingerprint shapes are detected. The
    fingerprint shapes can be oval-like shapes. The finger-
    print shape detection step detects the areas concentrated
    by black pixels that are comprised of oval-like shapes.”
    ’344 patent col.15 ll.46-49 (emphases added). Thus, by
    drawing a box around a fingerprint and detecting concen-
    trations of black pixels, the accused products detect the
    fingerprint’s shape. The shape of the bounding box is
    dictated by the shape of the fingerprint; i.e., it corre-
    sponds to the height and width of the fingerprint. The
    teachings of the patent do not require a calculation or
    determination of whether anything is oval-like. Given
    inherent limitations in the process of fingerprint capture,
    fingerprints are rarely in the form of a perfect oval. While
    the fingerprint shapes can be “oval-like,” the patent
    specification notes that they need not be oval-shaped.
    ’344 patent col.15 ll.46-49. The Commission thus had
    sufficient support for its conclusion that step (f) can be
    SUPREMA, INC.   v. ITC                                    11
    satisfied by detecting the concentrations of black pixels
    using a box bounding the black pixels.
    Appellants’ argument that Cross Match limited the
    scope of step (f) during prosecution to specifically require
    detection of “oval-like shapes,” is also without merit. “A
    disclaimer must be ‘clear and unmistakable,’ and unclear
    prosecution history cannot be used to limit claims.”
    Cordis Corp. v. Boston Sci. Corp., 
    561 F.3d 1319
    , 1329
    (Fed. Cir. 2009) (citation omitted). Here, nothing in the
    prosecution history limits the claimed invention to detec-
    tion of only fingerprints that are of oval-like shape or
    mandates calculation of an oval. The patentee never
    mentioned “oval-like shape” in its remarks to the examin-
    er. The additional calculation and precision that Appel-
    lants advocate is simply not required by the patent. The
    specification places no limits on steps (e) or (f) beyond the
    bounding box used in the accused products. And the
    specification indicates that the concentration of black
    pixels can be used to determine both characteristics of
    fingerprint area and fingerprint shape. Therefore, we
    reject Appellants’ argument regarding prosecution dis-
    claimer.
    In sum, we hold that the Commissioner’s findings that
    the accused products directly infringe claim 19 are sup-
    ported by substantial evidence.
    D. Whether Suprema was Willfully Blind to Mentalix’s
    Infringement
    Appellants next dispute the Commission’s finding
    that Suprema is liable for induced infringement because
    Suprema was willfully blind to the fact that Mentalix
    would infringe of claim 19 of the ’344 patent when it
    received and employed Suprema’s scanners.
    A party who “actively induces infringement of a pa-
    tent” under 
    35 U.S.C. § 271
    (b) is liable for patent in-
    fringement if the party knows that the induced acts
    12                                      SUPREMA, INC.   v. ITC
    constitute patent infringement. Global-Tech Appliances,
    Inc. v. SEB S.A., 
    131 S. Ct. 2060
    , 2063 (2011). A defend-
    ant can be found liable for induced infringement if it has
    actual knowledge of the infringement, or if it is willfully
    blind to the infringement. 
    Id.
     The doctrine of willful
    blindness requires that “(1) the defendant must subjec-
    tively believe that there is a high probability that a fact
    exists and (2) the defendant must take deliberate actions
    to avoid learning of that fact.” 
    Id. at 2070
    .
    “The requisite intent to induce infringement may be
    inferred from all of the circumstances,” and may be estab-
    lished through circumstantial evidence.” Broadcom Corp.
    v. Qualcomm, Inc., 
    543 F.3d 683
    , 699 (Fed. Cir. 2008).
    The question of whether Suprema was willfully blind to
    Mentalix’s infringement is a question of fact. National
    Presto Indus. v. West Bend Co., 
    76 F.3d 1185
    , 1192 (Fed.
    Cir. 1996). The Commission’s findings of fact should be
    set aside only if they are not supported by substantial
    evidence. Intel Corp., 
    946 F.2d at 832
    .
    The Commission found Suprema liable for induced in-
    fringement based on the totality of the facts the Commis-
    sion believed evidenced Suprema’s willful blindness. See
    Joint Appendix (“J.A.”) A221-25. From the entirety of the
    record before us, we hold that the Commission’s conclu-
    sion regarding induced infringement is supported by
    substantial evidence.
    The Commission observed that, when Suprema devel-
    oped the accused products, it admitted to engaging in
    extensive market research on its competitors. Suprema
    also admitted to researching and identifying Cross
    Match’s patents, including the ’993 and ’562 patents.
    Suprema specifically studied the ’562 patent, which
    incorporates by reference in four portions of its specifica-
    tion the patent application (U.S. Patent Ser. No.
    10/345,420) that led to the ’344 patent. ’562 patent col
    1:11-14 (“The present application is related to . . . U.S.
    SUPREMA, INC.   v. ITC                                       13
    patent application Ser. No. 10/345,366 . . . which [is]
    incorporated by reference in [its] entiret[y].”); 
    id.
     col. 5:30-
    34, 39-42, 65-67. Following its extensive research, Su-
    prema successfully developed its scanners into the auto-
    capture, image quality checking, and automatic
    segmentation processes that are covered by claim 19 of
    the ’344 patent. The Commission noted that, because the
    ’562 and ’344 patents have overlapping inventors and
    share the same assignee, Cross Match, “a word search
    likely would have identified both patents.” J.A. A223.
    The Commission also found that, in developing the ac-
    cused products, Suprema was well-aware of competitor
    products, of Cross Match’s prominence in the fingerprint
    scanner market, and of Cross Match’s relevant ’562
    patent. The Commission found that Suprema’s market
    analysis was similar in scope to that performed by the
    accused infringer in Global-Tech, who was found liable for
    induced infringement based on a theory of willful blind-
    ness. See Global-Tech, 
    131 S. Ct. at 2071-72
     (noting that
    the accused infringer performed “market research” and
    “gather[ed] information as much as possible.”). Suprema
    asserts that during its extensive market research it failed
    to check to see if the related patent application referenced
    in the ’562 patent proceeded to mature into an issued
    patent. The Commission discounted this testimony. The
    Commission found it notable that the ’344 patent issued
    in April 2007, six months prior to the October 2007 issue
    date of the ’562 patent. Thus, had Suprema checked for
    the issuance of the ’344 patent at the time it was review-
    ing the ’562 patent, Suprema would have undoubtedly
    discovered that the ’344 patent had issued.
    Suprema and amicus Google, Inc. (“Google”) argue
    that a requirement to seek out every reference referred to
    in a competitor’s patent would place too high a burden on
    manufacturers to avoid a finding of willful blindness. We
    do not hold that such an exhaustive patent search is
    required in every instance. Nor do we find that the Com-
    14                                      SUPREMA, INC.   v. ITC
    mission predicated its willful blindness finding only upon
    such an obligation. Rather, given the similarities in
    content, inventorship, and ownership between the ’344
    and ’562 patents, and the facts that Suprema studied the
    ’562 patent during its extensive market analysis, was
    aware of Cross Match’s activities in the scanner field, and
    specifically targeted the market Cross Match serviced
    when developing its own products, we find, based on the
    totality of the circumstances, that the Commission had
    adequate evidence upon which to conclude that Suprema’s
    actions constituted willful blindness.
    Notably, the Commission found that “the record is re-
    plete” with evidence of Suprema’s efforts in aiding and
    abetting Mentalix to adapt Mentalix’s FedSubmit soft-
    ware to work with Suprema’s imported scanners and SDK
    to practice claim 19 of the ’344 patent. The Commission
    then concluded that the totality of Suprema’s actions
    evidenced its subjective belief of the high probability that
    Cross Match’s scanner technology was patented, and
    further evidenced its deliberate actions to avoid learning
    of that fact. The Commission also found that Suprema
    deliberately avoided learning of the fact that Suprema’s
    own accused products would likely infringe Cross Match’s
    patents. The Commission’s findings are supported by
    substantial record evidence, and the Commission correctly
    concluded that those factual findings are sufficient to
    support a finding of willful blindness. See Global-Tech,
    
    131 S. Ct. at 2070-71
    .
    The Commission also found that Suprema’s failure to
    obtain an opinion of counsel constituted an additional fact
    evidencing Suprema’s willful blindness. The Commission
    noted that, had an opinion of counsel been sought, it
    would have “undoubtedly uncovered the ’344 patent, the
    fact that both the ’344 and ’562 patents are assigned to
    Cross Match, and would have analyzed whether Suprema
    infringed any of the Cross Match patents.” J.A. 224.
    Thus, the Commission found that Suprema was willfully
    SUPREMA, INC.   v. ITC                                    15
    blind to the existence of the ’344 patent and the nature of
    the infringing activities it actively encouraged Mentalix to
    perform. We do not find these findings to be without
    adequate support, as Suprema claims.
    The failure to obtain counsel opinion goes to the “state
    of mind” inducement requirement, and “such evidence
    remains relevant to the . . . intent analysis” for induce-
    ment. 2 Broadcom, 
    543 F.3d at 699
    . Thus, it was not error
    for the Commission to consider Suprema’s failure to
    obtain an opinion of counsel as a factor in their analysis of
    inducement. We do not hold that an opinion of counsel is
    required to avoid a finding of induced infringement. The
    failure to obtain an opinion of counsel is merely one fact of
    many that may be considered in the assessment of willful
    blindness. Broadcom, 
    543 F.3d at 698-701
    . Like the
    Commission, we do not place dispositive weight on Su-
    prema’s failure to obtain an opinion of counsel. While
    Global-Tech changed the standard of intent for establish-
    ing induced infringement, Global-Tech did not displace
    this Court’s holding in Broadcom that failure to obtain an
    opinion of counsel can be considered in determining
    whether the intent standard for induced infringement has
    been met. See Global-Tech, 
    131 S. Ct. at 2069-70
    . We
    thus reject Suprema’s argument that its failure to seek
    the opinion of counsel could not be considered as part of
    2    The America Invents Act (AIA) provides that
    “[t]he failure of an infringer to obtain the advice of coun-
    sel with respect to any allegedly infringed patent, or the
    failure of the infringer to present such advice to the court
    or jury, may not be used to prove that the accused infring-
    er willfully infringed the patent or that the infringer
    intended to induce infringement of the patent.” 
    35 U.S.C. § 298
    . Because the AIA only applies to patents issued on
    or after September 16, 2012, and the ’344 and ’562 pa-
    tents issued in 2007, this provision does not control here.
    16                                      SUPREMA, INC.   v. ITC
    the totality of circumstances indicating its willful blind-
    ness to Mentalix’s infringement.
    In its amicus brief, Google argues that the Commis-
    sion’s willful blindness ruling imposes too onerous a duty
    on innovators to ensure that its customers will not poten-
    tially infringe a patent. Google asserts that the Commis-
    sion’s ruling upsets the balance struck in Global-Tech. It
    is nearly impossible, Google argues, for a technology
    company to identify “all patents that are potentially
    implicated” by customers’ potential infringement of pa-
    tents. While we are not unmindful of these concerns, we
    do not find them sufficiently implicated in this present
    controversy to warrant a different outcome. We note,
    moreover, our deferential standard of review, which
    requires us to defer to the Commission’s factual findings if
    supported by substantial evidence. Our holding is limited
    to the facts in the case before us. None of the facts upon
    which the Commission relied, in isolation, would support
    a finding of willful blindness. Yet, while no single factor
    is dispositive here, we are satisfied that there is substan-
    tial evidence on this record to support the Commission’s
    findings.
    CONCLUSION
    For the foregoing reasons, we affirm the Commission’s
    findings with respect to the ’344 patent. We further
    reinstate the original panel’s opinion with respect to the
    ’562 and ’993 patents (Parts III.A, III.B, and V of the
    panel opinion). See Suprema I, 742 F.3d at 1363-71.
    Accordingly, we affirm.
    AFFIRMED